Published in Int J Cancer on November 27, 1997
Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc Natl Acad Sci U S A (2007) 2.22
Proteomic contributions to personalized cancer care. Mol Cell Proteomics (2008) 1.46
Nuclear envelope structural defect underlies the main cause of aneuploidy in ovarian carcinogenesis. BMC Cell Biol (2016) 1.37
Lamins at a glance. J Cell Sci (2012) 1.30
The role of protein synthesis in cell cycling and cancer. Mol Oncol (2009) 1.03
Diagnosis of Ovarian Cancer Using Decision Tree Classification of Mass Spectral Data. J Biomed Biotechnol (2003) 1.00
Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray. J Cancer Res Clin Oncol (2006) 0.99
Comparative proteomic study of two closely related ovarian endometrioid adenocarcinoma cell lines using cIEF fractionation and pathway analysis. Electrophoresis (2009) 0.97
In-depth identification of pathways related to cisplatin-induced hepatotoxicity through an integrative method based on an informatics-assisted label-free protein quantitation and microarray gene expression approach. Mol Cell Proteomics (2011) 0.90
Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin. Mol Cell Biol (2002) 0.90
Overexpression of kinase suppressor of Ras upregulates the high-molecular-weight tropomyosin isoforms in ras-transformed NIH 3T3 fibroblasts. Mol Cell Biol (2003) 0.90
Undifferentiated pelvic adenocarcinomas: diagnostic potential of protein profiling and multivariate analysis. Int J Colorectal Dis (2008) 0.88
Elongation factor 2 diphthamide is critical for translation of two IRES-dependent protein targets, XIAP and FGF2, under oxidative stress conditions. Free Radic Biol Med (2013) 0.83
Identification and characterization of tropomyosin 3 associated with granulin-epithelin precursor in human hepatocellular carcinoma. PLoS One (2012) 0.82
Downregulation of stathmin 1 in human gallbladder carcinoma inhibits tumor growth in vitro and in vivo. Sci Rep (2016) 0.80
Identification and characterization of a spontaneous ovarian carcinoma in Lewis rats. J Ovarian Res (2010) 0.79
Transformation, translation and TRAIL: an unexpected intersection. Cytokine Growth Factor Rev (2008) 0.78
Bouvardin is a Radiation Modulator with a Novel Mechanism of Action. Radiat Res (2015) 0.78
Protein signatures as potential surrogate biomarkers for stratification and prediction of treatment response in chronic myeloid leukemia patients. Int J Oncol (2016) 0.77
Ophiobolin A Induces Autophagy and Activates the Mitochondrial Pathway of Apoptosis in Human Melanoma Cells. PLoS One (2016) 0.75
Targeting translation initiation in breast cancer. Translation (Austin) (2014) 0.75
Effect of linear alkylbenzene sulfonate (LAS) on human intestinal Caco-2 cells at non cytotoxic concentrations. Cytotechnology (2015) 0.75
Elevated eukaryotic elongation factor 2 expression is involved in proliferation and invasion of lung squamous cell carcinoma. Oncotarget (2016) 0.75
The global carbon cycle: a test of our knowledge of earth as a system. Science (2000) 5.61
Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA (1999) 4.71
Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study. Am J Clin Nutr (1999) 4.15
Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer (1996) 3.30
Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci U S A (1996) 2.81
Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations. Genes Chromosomes Cancer (2000) 2.73
Agarose gel electrophoresis. Clin Chem (1979) 2.72
Identification of SopE2 from Salmonella typhimurium, a conserved guanine nucleotide exchange factor for Cdc42 of the host cell. Mol Microbiol (2000) 2.48
Stereotactic fine-needle biopsy in 2594 mammographically detected non-palpable lesions. Lancet (1989) 2.22
Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer (1999) 2.19
Derived pulmonary capillary pressure changes after smoke inhalation in sheep. Crit Care Med (1991) 2.15
Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Genes Chromosomes Cancer (1997) 2.06
The NAF domain defines a novel protein-protein interaction module conserved in Ca2+-regulated kinases. EMBO J (2001) 1.91
Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma. J Natl Cancer Inst (1997) 1.91
Constraints to growth of boreal forests. Nature (2000) 1.87
Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science (1996) 1.82
Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1). Mol Cell Biol (1994) 1.77
Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas. FEBS Lett (1999) 1.68
Typing of genetic variants of alpha 1-antitrypsin by electrofocusing. Clin Chem (1982) 1.59
Prevention of tumour cell dissemination in diagnostic needle procedures. Br J Cancer (2010) 1.57
Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients. Cancer Res (1996) 1.55
The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. Eur J Cancer (2001) 1.48
A novel adenovirus-2 E1A mRNA encoding a protein with transcription activation properties. EMBO J (1987) 1.47
Infantile multiple sclerosis with extensive white matter lesions. Pediatr Neurol (1989) 1.39
PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas. Br J Cancer (2007) 1.34
A novel assay for discovery and characterization of pro-apoptotic drugs and for monitoring apoptosis in patient sera. Apoptosis (2003) 1.30
Swimming-associated cryptosporidiosis. Am J Public Health (1992) 1.29
Laminin-5 as a marker of invasiveness in cervical lesions. J Natl Cancer Inst (1999) 1.25
Potent and selective agonism of the melanocortin receptor 4 with MK-0493 does not induce weight loss in obese human subjects: energy intake predicts lack of weight loss efficacy. Clin Pharmacol Ther (2009) 1.24
High temporal resolution tracing of photosynthate carbon from the tree canopy to forest soil microorganisms. New Phytol (2007) 1.24
Measurement of an apoptotic product in the sera of breast cancer patients. Eur J Cancer (2003) 1.24
Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans. Cancer Res (1984) 1.23
Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy. Cancer Res (1996) 1.23
Epithelial-myoepithelial duct carcinoma of salivary glands: a follow-up and cytophotometric study of 21 cases. J Oral Pathol Med (1989) 1.23
Prognostic factors for adenoid cystic carcinoma of the head and neck: a retrospective evaluation of 96 cases. J Oral Pathol Med (1990) 1.20
The interactions of the flavivirus envelope proteins: implications for virus entry and release. Arch Virol Suppl (1994) 1.20
Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg (1992) 1.19
The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent actin nucleation. J Biol Chem (2001) 1.18
Yersinia enterocolitica invasin triggers phagocytosis via beta1 integrins, CDC42Hs and WASp in macrophages. Cell Microbiol (2001) 1.13
Proliferative activity and cytochemical properties of nuclear chromatin related to local cell density of epithelial cells. Exp Cell Res (1970) 1.13
Cancer proteomics: from identification of novel markers to creation of artifical learning models for tumor classification. Electrophoresis (2000) 1.11
Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients. Br J Cancer (2008) 1.09
The effect of tobacco consumption and body mass index on complications and hospital stay after inguinal hernia surgery. Hernia (2006) 1.09
Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial. Arch Intern Med (2000) 1.09
Assessment of malignancy potential in so-called interval mammary carcinomas. Breast Cancer Res Treat (1985) 1.08
Cisplatin induces the proapoptotic conformation of Bak in a deltaMEKK1-dependent manner. Mol Cell Biol (2001) 1.07
Archaeology of Archaea: geomicrobiological record of Pleistocene thermal events concealed in a deep-sea subseafloor environment. Extremophiles (2001) 1.07
Tumor cytogenetics revisited: comparative genomic hybridization and spectral karyotyping. J Mol Med (Berl) (1998) 1.07
Docetaxel induces apoptosis in hormone refractory prostate carcinomas during multiple treatment cycles. Br J Cancer (2006) 1.06
Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma. Br J Cancer (2003) 1.05
Expression of tropomyosin isoforms in benign and malignant human breast lesions. Br J Cancer (1996) 1.05
Sequential proteome alterations during genesis and progression of colon cancer. Cell Mol Life Sci (2004) 1.04
Use of ion-exchange resins to prepare 100 microm-sized microcapsules with prolonged drug-release by the Wurster process. Int J Pharm (2001) 1.04
Independent expression of serum vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients with carcinoma and sarcoma. Anticancer Res (1998) 1.03
Cerebrospinal fluid concentrations of interleukin-1 beta, tumour necrosis factor-alpha, and interferon gamma in bacterial meningitis. Arch Dis Child (1994) 1.02
Two novel adenovirus vector systems permitting regulated protein expression in gene transfer experiments. J Virol (1998) 1.02
Quantitative cytochemical aspects of a combined feulgen-naphthol yellow S staining procedure for the simultaneous determination of nuclear and cytoplasmic proteins and DNA in mammalian cells. Exp Cell Res (1975) 1.02
Pachymeningitis associated with a pulmonary nodule. Neurosurgery (1991) 1.02
ERK signalling in metastatic human MDA-MB-231 breast carcinoma cells is adapted to obtain high urokinase expression and rapid cell proliferation. Clin Exp Metastasis (1999) 1.01
Detection of epithelial cell death in the body by cytokeratin 18 measurement. Biomed Pharmacother (2005) 1.00
Retinoic acid-induced differentiation of F9 embryonal carcinoma cells. Exp Cell Res (1981) 1.00
Mutational analysis of polyomavirus small-T-antigen functions in productive infection and in transformation. J Virol (1989) 1.00
Correlation between stromelysin-3 mRNA level and outcome of human breast cancer. Int J Cancer (1994) 1.00
Fluoxetine treatment of the obese diabetic. Int J Obes Relat Metab Disord (1992) 1.00
Use of relative weight and Body Mass Index for the determination of adiposity. J Clin Epidemiol (1991) 0.99
A population-based five-year follow-up study of cervical human papillomavirus infection. Am J Obstet Gynecol (2000) 0.98
Analysis of polypeptide expression in benign and malignant human breast lesions. Electrophoresis (1997) 0.98
Enhanced expression of matrix metalloproteinase-9 in abdominal aortic aneurysms. World J Surg (2001) 0.97
Up-regulation of human secreted frizzled homolog in apoptosis and its down-regulation in breast tumors. Int J Cancer (1998) 0.97
Evaluation of retinoblastoma and Ki-67 immunostaining as diagnostic markers of benign and malignant parathyroid disease. World J Surg (1999) 0.97
The carboxy-terminal exon of the adenovirus E1A protein is required for E4F-dependent transcription activation. EMBO J (1992) 0.97
Expression of coronin-3 (coronin-1C) in diffuse gliomas is related to malignancy. J Pathol (2008) 0.97
Independent transformation activity by adenovirus-5 E1A-conserved regions 1 or 2 mutants. Virology (1991) 0.97
Identification of two distinct deleted regions on chromosome 13 in prostate cancer. Oncogene (1998) 0.96
Mean canopy stomatal conductance responses to water and nutrient availabilities in Picea abies and Pinus taeda. Tree Physiol (2001) 0.96
Analysis of polypeptide expression in benign and malignant human breast lesions: down-regulation of cytokeratins. Br J Cancer (1996) 0.96
Specific demonstration of drug-induced tumour cell apoptosis in human xenografts models using a plasma biomarker. Cancer Biomark (2009) 0.95
Infections after hysterectomy. A prospective nation-wide Swedish study. The Study Group on Infectious Diseases in Obstetrics and Gynecology within the Swedish Society of Obstetrics and Gynecology. Acta Obstet Gynecol Scand (1996) 0.95
Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas. Br J Cancer (2006) 0.95
Characterization of gene expression in clinical lung cancer materials by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis (1994) 0.95
Fatal diffuse atheromatous embolization following endovascular grafting for an abdominal aortic aneurysm: report of a case. Surg Today (2001) 0.95
Functional changes of aorta with massive accumulation of calcium. Atherosclerosis (1989) 0.94
Association of membrane and cytoplasmic proteins with the cytoskeleton in blood platelets. Biochemistry (1982) 0.94
Genesis of squamous cell lung carcinoma. Sequential changes of proliferation, DNA ploidy, and p53 expression. Am J Pathol (1994) 0.94
In situ quantification of HER2-protein tyrosine kinase 6 (PTK6) protein-protein complexes in paraffin sections from breast cancer tissues. Br J Cancer (2010) 0.94